{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T13:49:34Z","timestamp":1783777774381,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.saa.2023.123823","type":"journal-article","created":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T17:38:03Z","timestamp":1704044283000},"page":"123823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Eco-friendly novel deconvoluted synchronous spectrofluorimetric approach for the determination of favipiravir, levodropropizine and moxifloxacin hydrochloride as an effective therapeutic combination for COVID-19; application in laboratory prepared mixtures and spiked human plasma"],"prefix":"10.1016","volume":"309","author":[{"given":"Eman A.","family":"Madbouly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalla A.","family":"El-Shanawani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobhy M.","family":"El-adl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2198-0549","authenticated-orcid":false,"given":"Ahmed S.","family":"Abdelkhalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.saa.2023.123823_b0005","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1038\/s41467-020-18463-z","article-title":"Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis","volume":"11","author":"Shannon","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.saa.2023.123823_b0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cmrp.2020.04.001","article-title":"An overview of coronaviruses including the SARS-2 coronavirus\u2013molecular biology, epidemiology and clinical implications","volume":"10","author":"Kaul","year":"2020","journal-title":"Curr. Med. Res. Pract."},{"key":"10.1016\/j.saa.2023.123823_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.621735","article-title":"Infection mechanism of SARS-COV-2 and its implication on the nervous system","volume":"11","author":"Reza-Zald\u00edvar","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.saa.2023.123823_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.704205","article-title":"The drug repurposing for COVID-19 clinical trials provide very effective therapeutic combinations: lessons learned from major clinical studies","volume":"12","author":"Chakraborty","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.saa.2023.123823_b0025","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1080\/07391102.2020.1802345","article-title":"Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2","volume":"39","author":"Siddiqui","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.saa.2023.123823_b0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.procbio.2020.12.014","article-title":"Rapid determination of remdesivir (SARS-CoV-2 drug) in human plasma for therapeutic drug monitoring in COVID-19-Patients","volume":"102","author":"Pasupuleti","year":"2021","journal-title":"Process Biochem."},{"key":"10.1016\/j.saa.2023.123823_b0035","doi-asserted-by":"crossref","first-page":"11022","DOI":"10.1038\/s41598-021-90551-6","article-title":"The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials","volume":"11","author":"Hassanipour","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.saa.2023.123823_b0040","unstructured":"\u0130. Bulduk, Comparison of HPLC and UV spectrophotometric methods for quantification of favipiravir in pharmaceutical formulations, Iran. J. Pharm. Res.: IJPR, 20 (2021) 57, 10.22037\/ijpr.2020.114199.14725."},{"key":"10.1016\/j.saa.2023.123823_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1022605","article-title":"Development and validation of method for analysis of favipiravir and remdesivir in volumetric absorptive microsampling with ultra high-performance liquid chromatography\u2013tandem mass spectrophotometry","volume":"10","author":"Harahap","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.saa.2023.123823_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2021.106189","article-title":"Green micellar solvent-free HPLC and spectrofluorimetric determination of favipiravir as one of COVID-19 antiviral regimens","volume":"165","author":"Mikhail","year":"2021","journal-title":"Microchem. J."},{"key":"10.1016\/j.saa.2023.123823_b0055","doi-asserted-by":"crossref","unstructured":"R. Nadendla, P. Abhinandana, A validated high performance liquid chromatographic method for the quantification of favipiravir by PDA detector.(2021), Int. J. Life Sci. Pharma Res, 11 (2021) 181-188, 10.3390\/molecules26133789.","DOI":"10.22376\/ijpbs\/lpr.2021.11.2.P181-188"},{"key":"10.1016\/j.saa.2023.123823_b0060","doi-asserted-by":"crossref","unstructured":"V. Nishanth G, T. Spandana, C.D. Sri, V. Nataraj, P.H. Vikram, B. Gurupadayya, Multivariate optimization for determination of favipiravir, a SARS-CoV-2 molecule, by the reverse-phase liquid chromatographic method using a QbD approach, J. Chromatogr. Sci., (2022) bmac041, 10.1093\/chromsci\/bmac041.","DOI":"10.1093\/chromsci\/bmac041"},{"key":"10.1016\/j.saa.2023.123823_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115131","article-title":"Fabric phase sorptive extraction combined with high performance liquid chromatography for the determination of favipiravir in human plasma and breast milk","volume":"223","author":"Tiris","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2023.123823_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2021.106917","article-title":"A novel stability-indicating HPLC-DAD method for determination of favipiravir, a potential antiviral drug for COVID-19 treatment; application to degradation kinetic studies and in-vitro dissolution profiling","volume":"172","author":"Marzouk","year":"2022","journal-title":"Microchem. J."},{"key":"10.1016\/j.saa.2023.123823_b0075","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/bios13020243","article-title":"An innovative polymer-based electrochemical sensor encrusted with Tb nanoparticles for the detection of favipiravir: a potential antiviral drug for the treatment of COVID-19","volume":"13","author":"Ali","year":"2023","journal-title":"Biosensors"},{"key":"10.1016\/j.saa.2023.123823_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.338418","article-title":"First electrochemical evaluation of favipiravir used as an antiviral option in the treatment of COVID-19: A study of its enhanced voltammetric determination in cationic surfactant media using a boron-doped diamond electrode","volume":"1159","author":"Allahverdiyeva","year":"2021","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.saa.2023.123823_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jelechem.2022.116745","article-title":"Nanocomposite of gold nanoparticles@ nickel disulfide-plant derived carbon for molecularly imprinted electrochemical determination of favipiravir","volume":"922","author":"El-Wekil","year":"2022","journal-title":"J. Electroanal. Chem."},{"key":"10.1016\/j.saa.2023.123823_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00604-021-05107-2","article-title":"Voltammetric sensor based on bimetallic nanocomposite for determination of favipiravir as an antiviral drug","volume":"188","author":"Mehmandoust","year":"2021","journal-title":"Microchim. Acta"},{"key":"10.1016\/j.saa.2023.123823_b0095","doi-asserted-by":"crossref","DOI":"10.5530\/ijpi.13.2.039","volume":"13","author":"Chakraborty","year":"2023","journal-title":"Int. J. Pharm. Invest."},{"key":"10.1016\/j.saa.2023.123823_b0100","doi-asserted-by":"crossref","unstructured":"W.A. Panchale, S.B. Bisen, J.V. Manwar, R.L. Bakal, T.V. Tidke, M.N. Paithankar, A.G. Vakhare, Development of visible spectrophotometric methods for the analysis of favipiravir in pure drug and tablet formulation, GSC Biol. Pharm. Sci., 20 (2022) 184-195, 10.30574\/gscbps.2022.20.2.0320.","DOI":"10.30574\/gscbps.2022.20.2.0320"},{"key":"10.1016\/j.saa.2023.123823_b0105","doi-asserted-by":"crossref","unstructured":"R.V. Rele, P.P. Tiwatane, Simple extractive spectrophotometric method for determination of favipiravir from pharmaceutical formulation, (2022), 10.52711\/0974-4150.2022.00053.","DOI":"10.52711\/0974-4150.2022.00053"},{"key":"10.1016\/j.saa.2023.123823_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2020.119241","article-title":"Experimental design approach for development of spectrofluorimetric method for determination of favipiravir; a potential therapeutic agent against COVID-19 virus: Application to spiked human plasma","volume":"249","author":"Megahed","year":"2021","journal-title":"Spectrochim. Acta Part A: Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2023.123823_b0115","doi-asserted-by":"crossref","DOI":"10.5530\/ijpi.13.3.071","article-title":"Stability indicating HPTLC method development and validation for quantification of favipiravir in bulk and commercial film coated tablet","volume":"13","author":"Balap","year":"2023","journal-title":"Int. J. Pharm. Invest."},{"key":"10.1016\/j.saa.2023.123823_b0120","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3390\/molecules28020529","article-title":"A non-instrumental green analytical method based on surfactant-assisted dispersive liquid\u2013liquid microextraction\u2013thin-layer chromatography\u2013smartphone-based digital image colorimetry (SA-DLLME-TLC-SDIC) for determining favipiravir in biological samples","volume":"28","author":"Jain","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.saa.2023.123823_b0125","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.resp.2005.11.010","article-title":"Current and future peripherally-acting antitussives","volume":"152","author":"Dicpinigaitis","year":"2006","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.saa.2023.123823_b0130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0952-0600(92)90033-D","article-title":"Peripheral site of action of levodropropizine in experimentally-induced cough: role of sensory neuropeptides","volume":"5","author":"Lavezzo","year":"1992","journal-title":"Pulm. Pharmacol."},{"key":"10.1016\/j.saa.2023.123823_b0135","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/704564","article-title":"Sensitive spectrophotometric method for quantitation of guaifenesin and dropropizine in their dosage forms","volume":"2010","author":"Abdallah","year":"2010","journal-title":"Int. J. Anal. Chem."},{"key":"10.1016\/j.saa.2023.123823_b0140","doi-asserted-by":"crossref","unstructured":"M.A. Monsores, M.P. Caet, A.K.M. Machado, M.C. Nemitz, V. Todeschini, M. da Silva Sangoi, Validation of a green spectrophotometric method for the determination of dropropizine in commercial oral solutions, Drug Anal. Res., 4 (2020) 12-18, 10.22456\/2527-2616.108127.","DOI":"10.22456\/2527-2616.108127"},{"key":"10.1016\/j.saa.2023.123823_b0145","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3797\/scipharm.1210-18","article-title":"Development and validation of a stability-indicating LC-method for the simultaneous estimation of levodropropizine, chloropheniramine, methylparaben, propylparaben, and levodropropizine impurities","volume":"81","author":"Kumar","year":"2013","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.saa.2023.123823_b0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0378-4347(96)00163-6","article-title":"High-performance liquid chromatographic determination of levodropropizine in human plasma with fluorometric detection","volume":"685","author":"Tagliaro","year":"1996","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.saa.2023.123823_b0155","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jchromb.2005.01.029","article-title":"Rapid and sensitive liquid chromatography\u2013tandem mass spectrometry method for the quantitation of levodropropizine in human plasma","volume":"819","author":"Tang","year":"2005","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.saa.2023.123823_b0160","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.4067\/S0717-97072015000400018","article-title":"Simultaneous determination of levodropropizine, methylparaben, and propylparaben in oral co-formulated syrup by RP-HPLC method","volume":"60","author":"Weshahy","year":"2015","journal-title":"J. Chil. Chem. Soc."},{"key":"10.1016\/j.saa.2023.123823_b0165","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/1573412911309030008","article-title":"Electroanalytical characterization of levodropropizine and its voltammetric determination in pharmaceuticals","volume":"9","author":"Agin","year":"2013","journal-title":"Curr. Pharm. Anal."},{"key":"10.1016\/j.saa.2023.123823_b0170","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1016\/S1452-3981(23)06536-7","article-title":"Voltammetric determination of the cough suppressant drug dropropizine in its pharmaceutical formulations and human urine","volume":"10","author":"Zayed","year":"2015","journal-title":"Int. J. Electrochem. Sci."},{"key":"10.1016\/j.saa.2023.123823_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-021-00444-9","article-title":"Repurposing of antibiotics for clinical management of COVID-19: a narrative review","volume":"20","author":"Yacouba","year":"2021","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.saa.2023.123823_b0180","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s43440-020-00169-0","article-title":"Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis","volume":"72","author":"Marciniec","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.saa.2023.123823_b0185","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.52711\/0974-360X.2021.00332","article-title":"Development, optimization, and validation of a green spectrofluorimetric method for the determination of moxifloxacin using an experimental design approach","volume":"14","author":"Ibrahim","year":"2021","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.saa.2023.123823_b0190","first-page":"616","article-title":"Micellar-enhanced spectrofluorometric quantification of moxifloxacin in pharmaceutical formulations, human urine and plasma samples","volume":"5","author":"Jasmin","year":"2011","journal-title":"Afr. J. Pharm. Pharmacol"},{"key":"10.1016\/j.saa.2023.123823_b0195","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2921417","article-title":"Fiberoptic-coupled spectrofluorometer with array detection as a process analytical chemistry tool for continuous flow monitoring of fluoroquinolone antibiotics","volume":"2020","author":"Shokoufi","year":"2020","journal-title":"Int. J. Anal. Chem."},{"key":"10.1016\/j.saa.2023.123823_b0200","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jchromb.2009.02.042","article-title":"Simple and rapid liquid chromatography method for determination of moxifloxacin in plasma","volume":"877","author":"Kumar","year":"2009","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.saa.2023.123823_b0205","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1016\/j.jchromb.2011.09.047","article-title":"Simple and rapid liquid chromatography method for determination of moxifloxacin in saliva","volume":"879","author":"Kumar","year":"2011","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.saa.2023.123823_b0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jat\/34.3.135","article-title":"Determination of moxifloxacin in human plasma, plasma ultrafiltrate, and cerebrospinal fluid by a rapid and simple liquid chromatography-tandem mass spectrometry method","volume":"34","author":"Pranger","year":"2010","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.saa.2023.123823_b0215","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jpba.2006.06.026","article-title":"High-performance liquid chromatography assay for moxifloxacin: pharmacokinetics in human plasma","volume":"43","author":"Ulu","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2023.123823_b0220","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0731-7085(02)00393-X","article-title":"Determination of moxifloxacin in human plasma by liquid chromatography electrospray ionization tandem mass spectrometry","volume":"30","author":"Vishwanathan","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2023.123823_b0225","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1570-0232(04)00593-8","article-title":"Simultaneous determination of levofloxacin, gatifloxacin and moxifloxacin in serum by liquid chromatography with column switching","volume":"810","author":"Nguyen","year":"2004","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.saa.2023.123823_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-153X-6-105","article-title":"Simultaneous determination of moxifloxacin and cefixime by first and ratio first derivative ultraviolet spectrophotometry","volume":"6","author":"Attimarad","year":"2012","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.saa.2023.123823_b0235","article-title":"New spectrophotometric methods for the determination of moxifloxacin in pharmaceutical formulations","volume":"60","author":"Elbashir","year":"2013","journal-title":"Acta Chim. Slov."},{"key":"10.1016\/j.saa.2023.123823_b0240","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.saa.2006.11.023","article-title":"Validated spectrophotometric methods for the estimation of moxifloxacin in bulk and pharmaceutical formulations","volume":"68","author":"Motwani","year":"2007","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2023.123823_b0245","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/2229-4708.72232","article-title":"A validated HPTLC method for estimation of moxifloxacin hydrochloride in tablets","volume":"1","author":"Dhillon","year":"2010","journal-title":"Pharm. Methods"},{"key":"10.1016\/j.saa.2023.123823_b0250","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.aca.2006.08.053","article-title":"Application of a validated stability-indicating densitometric thin-layer chromatographic method to stress degradation studies on moxifloxacin","volume":"582","author":"Motwani","year":"2007","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.saa.2023.123823_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2023.116964","article-title":"Analytical approaches for determination of COVID-19 candidate drugs in human biological matrices","author":"Mahdavi","year":"2023","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.saa.2023.123823_b0260","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","article-title":"A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index","volume":"181","author":"P\u0142otka-Wasylka","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.saa.2023.123823_b0265","volume":"157","author":"Mohamed","year":"2020","journal-title":"Microchem. J."},{"key":"10.1016\/j.saa.2023.123823_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2022.122114","article-title":"Novel deconvoluted synchronous spectrofluorimetric method for simultaneous determination of bisoprolol and atorvastatin as single or co-administrated drugs in bulk and plasma; green assessment","volume":"287","author":"Attia","year":"2023","journal-title":"Spectrochim. Acta Part A: Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2023.123823_b0275","unstructured":"United States Pharmacopoeia 30 National formulary 24, United State pharmacopoeia Convention, (2007)."},{"key":"10.1016\/j.saa.2023.123823_b0280","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jchromb.2016.03.002","article-title":"Simultaneous determination of moxifloxacin and ofloxacin in physiological fluids using high performance liquid chromatography with ultraviolet detection","volume":"1017","author":"Khan","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.saa.2023.123823_b0285","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","article-title":"Analytical Eco-Scale for assessing the greenness of analytical procedures","volume":"37","author":"Ga\u0142uszka","year":"2012","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.saa.2023.123823_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2021.123046","article-title":"Green analytical chemistry metrics: A review","volume":"238","author":"Sajid","year":"2022","journal-title":"Talanta"},{"key":"10.1016\/j.saa.2023.123823_b0295","doi-asserted-by":"crossref","unstructured":"R. G\u00fclhan, E. Ery\u00fcksel, M. G\u00fcl\u00e7ebi \u0130driz O\u011flu, Y. \u00c7ulpan, A. Toplu, D. Kocakaya, E. Tigen, B. Ert\u00fcrk \u015eengel, U. Sili, \u015e. Olgun Y\u0131ld\u0131zeli, Pharmacokinetic characterization of favipiravir in patients with COVID\u201019, Br. J. Clin. Pharmacol., 88 (2022) 3516-3522, 10.1111\/bcp.15227.","DOI":"10.1111\/bcp.15227"},{"key":"10.1016\/j.saa.2023.123823_b0300","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2147\/DDDT.S146958","article-title":"Evaluation of the effects of food on levodropropizine controlled-release tablet and its pharmacokinetic profile in comparison to that of immediate-release tablet","author":"Lee","year":"2018","journal-title":"Drug Design Dev. Ther."},{"key":"10.1016\/j.saa.2023.123823_b0305","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1358\/dot.2000.36.4.570201","article-title":"Pharmacokinetics and metabolism of moxifloxacin","volume":"36","author":"Moise","year":"2000","journal-title":"Drugs Today (Barcelona, Spain: 1998)"}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142523015081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142523015081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T02:37:34Z","timestamp":1761359854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142523015081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":61,"alternative-id":["S1386142523015081"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2023.123823","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eco-friendly novel deconvoluted synchronous spectrofluorimetric approach for the determination of favipiravir, levodropropizine and moxifloxacin hydrochloride as an effective therapeutic combination for COVID-19; application in laboratory prepared mixtures and spiked human plasma","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2023.123823","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123823"}}